Search research articles
Contact Us
Filters
Showing results (151-160 of 176) with videos related to
Page
of 18
Sort By:
Cancer
|
June 1, 2016
Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes
Gevorg N Tamamyan, Hagop M Kantarjian, Jing Ning, et al.
American Journal of Hematology
|
November 12, 2020
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes
Koji Sasaki, Elias J Jabbour, Farhad Ravandi, et al.
Frontiers in Oncology
|
September 26, 2024
Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs
Gohar S Manzar, Elaine E Cha, Kelsey L Corrigan, et al.
Cancer
|
July 26, 2017
Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients
Preetesh Jain, Hagop M Kantarjian, Ahmad Ghorab, et al.
Blood Cancer Journal
|
July 2, 2026
Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma
Karan L Chohan, Eduardo Edelman Saul, R Eric Davis, et al.
Leukemia
|
September 28, 2019
Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma
Michael Wang, Simon Rule, Pier Luigi Zinzani, et al.
Cancer
|
June 14, 2017
TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens
Rashmi Kanagal-Shamanna, Preetesh Jain, Koichi Takahashi, et al.
American Journal of Hematology
|
October 20, 2017
Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma
Yasmin Abaza, Hagop M Kantarjian, Stefan Faderl, et al.
Blood
|
July 23, 2025
TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma
Wei Wang, Qingsong Cai, Yang Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2021
Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma
Preetesh Jain, Shuangtao Zhao, Hun Ju Lee, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 176) with videos related to
Sort By:
Page
of 18
Cancer
|
June 1, 2016
Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes
Gevorg N Tamamyan, Hagop M Kantarjian, Jing Ning, et al.
American Journal of Hematology
|
November 12, 2020
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes
Koji Sasaki, Elias J Jabbour, Farhad Ravandi, et al.
Frontiers in Oncology
|
September 26, 2024
Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs
Gohar S Manzar, Elaine E Cha, Kelsey L Corrigan, et al.
Cancer
|
July 26, 2017
Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients
Preetesh Jain, Hagop M Kantarjian, Ahmad Ghorab, et al.
Blood Cancer Journal
|
July 2, 2026
Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma
Karan L Chohan, Eduardo Edelman Saul, R Eric Davis, et al.
Leukemia
|
September 28, 2019
Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma
Michael Wang, Simon Rule, Pier Luigi Zinzani, et al.
Cancer
|
June 14, 2017
TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens
Rashmi Kanagal-Shamanna, Preetesh Jain, Koichi Takahashi, et al.
American Journal of Hematology
|
October 20, 2017
Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma
Yasmin Abaza, Hagop M Kantarjian, Stefan Faderl, et al.
Blood
|
July 23, 2025
TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma
Wei Wang, Qingsong Cai, Yang Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2021
Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma
Preetesh Jain, Shuangtao Zhao, Hun Ju Lee, et al.
Page
of 18